MedPath

Prevention of pancreatic inflammation after endoscopy of the pancreas and bile duct with anti-inflammatory

Phase 4
Conditions
acute pancreatitis
k85.8
Registration Number
RBR-6zkm5k
Lead Sponsor
Julio Carlos Pereira Lima
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Eligible subjects were all adults who were scheduled to undergo ERCP at our institution.

Exclusion Criteria

Exclusion criteria were patients with known contraindication to ketoprofen use, active pancreatitis at the time of ERCP, previous ERCP and refusal to enter in the study.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath